A Comparative Study of SMN Protein and mRNA in Blood and Fibroblasts in Patients with Spinal Muscular Atrophy and Healthy Controls

BACKGROUND: Clinical trials to test safety and efficacy of drugs for patients with spinal muscular atrophy (SMA) are currently underway. Biomarkers that document treatment-induced effects are needed because disease progression in childhood forms of SMA is slow and clinical outcome measures may lack...

Descripción completa

Detalles Bibliográficos
Autores principales: Wadman, Renske I., Stam, Marloes, Jansen, Marc D., van der Weegen, Yana, Wijngaarde, Camiel A., Harschnitz, Oliver, Sodaar, Peter, Braun, Kees P. J., Dooijes, Dennis, Lemmink, Henny H., van den Berg, Leonard H., van der Pol, W. Ludo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125671/
https://www.ncbi.nlm.nih.gov/pubmed/27893852
http://dx.doi.org/10.1371/journal.pone.0167087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125671/
https://www.ncbi.nlm.nih.gov/pubmed/27893852
http://dx.doi.org/10.1371/journal.pone.0167087

Ejemplares similares